0001193125-26-354036.txt : 20260817
0001193125-26-354036.hdr.sgml : 20260817
20260817160603
ACCESSION NUMBER: 0001193125-26-354036
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20260817
DATE AS OF CHANGE: 20260817
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Invivyd, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
EIN: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 261286699
BUSINESS ADDRESS:
STREET 1: 205 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
BUSINESS PHONE: (781) 819-0080
MAIL ADDRESS:
STREET 1: 205 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
FORMER COMPANY:
FORMER CONFORMED NAME: Adagio Therapeutics, Inc.
DATE OF NAME CHANGE: 20201112
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lee Timothy Edward
CENTRAL INDEX KEY: 0002025331
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O INVIVYD, INC.
STREET 2: 205 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
144
1
primary_doc.xml
144
0002025331
XXXXXXXX
LIVE
0001832038
Invivyd, Inc.
001-40703
205 Church Street
New Haven
CT
06510
781-819-0080
Lee Timothy Edward
Officer
Common Stock
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
40800
29412.72
294758746
08/17/2026
Nasdaq
Common Stock
08/15/2026
Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan
Issuer
N
102000
08/15/2026
Equity Compensation
Y
This Form 144 reports shares to be sold to satisfy the Reporting Person's tax obligations upon vesting of a restricted stock unit award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan applicable to the Reporting Person. Aggregate Market Value of the sale is based on a closing price of $0.7209 for the Issuer's common stock on August 14, 2026. The actual number of shares sold will depend on the sale price of the Issuer's common stock at the time of sale.
08/17/2026
02/20/2025
/s/ Jill Andersen attorney-in-fact for Timothy Edward Lee